Neja Šamec

7PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersApplications in life sciencesGene and molecular therapyGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 21, 2025
In Vitro Functional Validation of an Anti-FREM2 Nanobody for Glioblastoma Cell Targeting.

Gloria Krapež, Neja Šamec, Alja Zottel

|Feb 11, 2023
Anti-Vimentin Nanobody Decreases Glioblastoma Cell Invasion In Vitro and In Vivo.

Alja Zottel, Metka Novak, Neja Šamec

|Oct 23, 2021
Current Technologies for RNA-Directed Liquid Diagnostics.

Maria Victoria Martinez-Dominguez, Alja Zottel, Neja Šamec

|Sep 10, 2021
TRIM28 Selective Nanobody Reduces Glioblastoma Stem Cell Invasion.

Andrej Porčnik, Metka Novak, Barbara Breznik

|Aug 27, 2021
Algorithmically Deduced FREM2 Molecular Pathway Is a Potent Grade and Survival Biomarker of Human Gliomas.

Marianna Zolotovskaia, Victor Tkachev, Maxim Sorokin

|Jul 24, 2021
Large-Scale Transcriptomics-Driven Approach Revealed Overexpression of CRNDE as a Poor Survival Prognosis Biomarker in Glioblastoma.

Maxim Sorokin, Mikhail Raevskiy, Alja Zottel

Pageof 2

Frequent Collaborators

7 joint publications

Alja Zottel

7 joint publications

Ivana Jovčevska

2 joint publications

Rok Romih

2 joint publications

Barbara Breznik